N
CELL

Nuveen’s PhenomeX Inc. Common Stock CELL Stock Holding History

Nuveen’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-214,012
Closed -$248K – 3340
2023
Q1 		$248K Sell
214,012
-2,115
-1% -$3.87K ﹤0.01% 2951
2022
Q4 		$579K Sell
216,127
-27,770
-11% -$73.2K ﹤0.01% 2846
2022
Q3 		$698K Sell
243,897
-3,018
-1% -$12.8K ﹤0.01% 2874
2022
Q2 		$1.23M Sell
246,915
-300,808
-55% -$1.58M ﹤0.01% 2697
2022
Q1 		$3.86M Buy
547,723
+92,707
+20% +$767K ﹤0.01% 2191
2021
Q4 		$7.79M Sell
455,016
-16,034
-3% -$346K ﹤0.01% 1837
2021
Q3 		$9.21M Buy
471,050
+35,868
+8% +$1.36M ﹤0.01% 1833
2021
Q2 		$19.5M Buy
435,182
+354,063
+436% +$16.4M 0.01% 1386
2021
Q1 		$4.07M Sell
81,119
-299,337
-79% -$20.4M ﹤0.01% 2259
2020
Q4 		$34M Sell
380,456
-22,173
-6% -$1.87M 0.01% 910
2020
Q3 		$30.7M Buy
+402,629
New +$25.6M 0.01% 813

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen's CELL Position: Q2 2023 in Review

Nuveen sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 214,012 shares — an estimated $248K sold.

Nuveen first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $34M in Q4 2020. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Nuveen reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 214,012 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $248K.
  • Nuveen first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Nuveen's PhenomeX Inc. Common Stock position peaked at $34M in Q4 2020.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.